{"id":68840,"date":"2026-02-25T16:10:01","date_gmt":"2026-02-25T16:10:01","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68840"},"modified":"2026-05-21T07:14:12","modified_gmt":"2026-05-21T07:14:12","slug":"nad","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/nad\/","title":{"rendered":"NAD\u207a"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Rychl\u00e1 odpov\u011b\u010f \u2014 Co je NAD+?<\/h3>\n<p style=\"margin: 0;\"><strong>NAD+<\/strong> (nikotinamidadenindinukleotid) je z\u00e1kladn\u00ed koenzym p\u0159\u00edtomn\u00fd v ka\u017ed\u00e9 bu\u0148ce, kl\u00ed\u010dov\u00fd pro energetick\u00fd metabolismus, signalizaci dlouhov\u011bkosti prost\u0159ednictv\u00edm sirtuinov\u00fdch drah a opravu DNA zprost\u0159edkovanou PARP. Bun\u011b\u010dn\u00e9 hladiny NAD+ s v\u011bkem v\u00fdrazn\u011b klesaj\u00ed, co\u017e z n\u011bj \u010din\u00ed jednu z nejstudovan\u011bj\u0161\u00edch molekul ve v\u00fdzkumu dlouhov\u011bkosti. Dod\u00e1v\u00e1 se v lyofilizovan\u00fdch vialk\u00e1ch o obsahu 100 mg a\u017e 1000 mg v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdzkumn\u00e9 lyofilizovan\u00e9 peptidy \u00b7 HPLC \u010distota \u226599% (COA na vy\u017e\u00e1d\u00e1n\u00ed) \u00b7 Diskr\u00e9tn\u00ed teplotn\u011b stabiln\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 p\u0159eprava peptid\u016f \u00b7 1,400+ ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifikace<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS \u010d\u00edslo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">53-84-9<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item2<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>21<\/sub>H<sub>27<\/sub>N<sub>7<\/sub>O<sub>14<\/sub>P<sub>2<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">663.43 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">n\/a (dinukleotidov\u00fd koenzym \u2014 nikoliv peptid)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item11<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00fd pr\u00e1\u0161ek (nebo v dodan\u00e9 form\u011b)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item13<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC ov\u011b\u0159eno, COA na vy\u017e\u00e1d\u00e1n\u00ed)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Skladov\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00fd p\u0159\u00edpravek: 2\u20138 \u00b0C (lednice) pro pracovn\u00ed z\u00e1sobu; \u221220 \u00b0C pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch vialek. Rekonstituovan\u00fd roztok: 2\u20138 \u00b0C, pou\u017e\u00edt do ~30 dn\u016f. Chra\u0148te p\u0159ed sv\u011btlem \u2014 NAD se snadno oxiduje. Roztok po rekonstituci nezmrazujte a nerozmrazujte.<sup>+<\/sup> Snadno oxiduje. Rekonstituovan\u00fd roztok nezmrazujte a nerozmrazujte.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Rozpustnost<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatick\u00e1 voda (doporu\u010deno) nebo steriln\u00ed voda pro krat\u0161\u00ed dobu pou\u017eit\u00ed<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pouze pro v\u00fdzkum<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pouze pro laboratorn\u00ed v\u00fdzkum. Nen\u00ed ur\u010deno pro diagnostick\u00e9 nebo terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed nebo zv\u00ed\u0159at.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>(nikotinamidadenindinukleotid) nen\u00ed striktn\u011b peptid \u2014 jde o dinukleotidov\u00fd koenzym slo\u017een\u00fd ze dvou nukleotid\u016f spojen\u00fdch fosf\u00e1tov\u00fdmi skupinami. Je v\u0161ak nejv\u00edce studovanou jednotlivou molekulou v literatu\u0159e o dlouhov\u011bkosti a bun\u011b\u010dn\u00e9m st\u00e1rnut\u00ed a b\u011b\u017en\u011b se dod\u00e1v\u00e1 prost\u0159ednictv\u00edm dodavatel\u016f peptidov\u00e9ho v\u00fdzkumu spolu s peptidov\u00fdmi slou\u010deninami pro pohodl\u00ed v\u00fdzkumn\u00edk\u016f pracuj\u00edc\u00edch na multifaktori\u00e1ln\u00edch studi\u00edch bun\u011b\u010dn\u00e9ho st\u00e1rnut\u00ed.<\/h2>\n<p><strong>NAD+<\/strong> (nikotinamidadenindinukleotid) nen\u00ed striktn\u011b peptid \u2014 je to dinukleotidov\u00fd koenzym slo\u017een\u00fd ze dvou nukleotid\u016f spojen\u00fdch p\u0159es sv\u00e9 fosf\u00e1tov\u00e9 skupiny. Je to v\u0161ak nejv\u00edce zkouman\u00e1 jednotliv\u00e1 molekula v literatu\u0159e o dlouhov\u011bkosti a bun\u011b\u010dn\u00e9m st\u00e1rnut\u00ed a b\u011b\u017en\u011b se dod\u00e1v\u00e1 prost\u0159ednictv\u00edm dodavatel\u016f peptidov\u00e9ho v\u00fdzkumu spolu s peptidov\u00fdmi slou\u010deninami pro pohodl\u00ed v\u00fdzkumn\u00edk\u016f pracuj\u00edc\u00edch na multifaktori\u00e1ln\u00edch studi\u00edch bun\u011b\u010dn\u00e9ho st\u00e1rnut\u00ed.<\/p>\n<p>NAD+ se nach\u00e1z\u00ed v ka\u017ed\u00e9 \u017eiv\u00e9 bu\u0148ce a funguje jako substr\u00e1t pro t\u0159i hlavn\u00ed enzymov\u00e9 rodiny: <strong>oxidoredukt\u00e1zy<\/strong> (energetick\u00fd metabolismus), <strong>sirtuiny<\/strong> (signalizace dlouhov\u011bkosti, uml\u010dov\u00e1n\u00ed gen\u016f), a <strong>PARPs<\/strong> (reakce na po\u0161kozen\u00ed DNA). Hladiny bun\u011b\u010dn\u00e9ho NAD+ klesaj\u00ed p\u0159ibli\u017en\u011b o 50 % mezi 30. a 70. rokem v\u011bku ve v\u011bt\u0161in\u011b tk\u00e1n\u00ed \u2013 tzv. \u201cpokles NAD+\u201d \u2013 a obnova t\u00e9to hladiny je kl\u00ed\u010dovou hypot\u00e9zou ve v\u00fdzkumu dlouhov\u011bkosti (Yoshino, Baur &amp; Imai, Cell Metab 2018).<\/p>\n<p>Molekulov\u00e1 hmotnost 663,4 Da, empirick\u00fd vzorec C<sub>21<\/sub>H<sub>27<\/sub>N<sub>7<\/sub>O<sub>14<\/sub>P<sub>2<\/sub>. Dod\u00e1v\u00e1 se jako vysoce \u010dist\u00fd lyofilizovan\u00fd pr\u00e1\u0161ek pro rekonstituci s bakteriostatickou vodou. NAD+ je <strong>ur\u010den pouze pro laboratorn\u00ed v\u00fdzkum<\/strong> a nen\u00ed ur\u010den pro hum\u00e1nn\u00ed nebo veterin\u00e1rn\u00ed diagnostiku \u010di terapii. Pro hlub\u0161\u00ed mechanismus, kontext v\u00fdzkumu dlouhov\u011bkosti a alternativn\u00ed prekurzorov\u00e9 slou\u010deniny (NR, NMN) viz n\u00e1\u0161 kompletn\u00ed <a href=\"https:\/\/medsbase.com\/cs\/nad-plus-coenzyme-longevity-guide\/\">pr\u016fvodce v\u00fdzkumem NAD+<\/a>.<\/p>\n<h2>Mechanismus \u00fa\u010dinku \u2014 t\u0159i kl\u00ed\u010dov\u00e9 dr\u00e1hy<\/h2>\n<p>NAD+ se pod\u00edl\u00ed na bun\u011b\u010dn\u00e9 biologii prost\u0159ednictv\u00edm t\u0159\u00ed mechanicky odli\u0161n\u00fdch, ale vz\u00e1jemn\u011b z\u00e1visl\u00fdch enzymov\u00fdch rodin:<\/p>\n<ul>\n<li><strong>Redoxn\u00ed koenzym (energetick\u00fd metabolismus)<\/strong> \u2014 NAD+ je centr\u00e1ln\u00edm p\u0159ena\u0161e\u010dem elektron\u016f v glykol\u00fdze, Krebsov\u011b cyklu a oxidativn\u00ed fosforylaci. Ka\u017ed\u00fd krok, kter\u00fd z\u00edsk\u00e1v\u00e1 energii z potravy, nakonec p\u0159en\u00e1\u0161\u00ed elektrony na NAD+ (za vzniku NADH), co\u017e n\u00e1sledn\u011b poh\u00e1n\u00ed synt\u00e9zu ATP v mitochondri\u00edch. Bez dostate\u010dn\u00e9ho mno\u017estv\u00ed NAD+ nemohou bu\u0148ky efektivn\u011b produkovat energii.<\/li>\n<li><strong>Aktivace sirtuin\u016f (signalizace dlouhov\u011bkosti)<\/strong> \u2014 sedm sav\u010d\u00edch sirtuin\u016f (SIRT1\u2013SIRT7) jsou NAD+-dependentn\u00ed deacetyl\u00e1zy, kter\u00e9 reguluj\u00ed uml\u010dov\u00e1n\u00ed gen\u016f, reakci na stres, biogenezi mitochondri\u00ed a opravu DNA. Kdy\u017e hladiny NAD+ klesaj\u00ed, aktivita sirtuin\u016f se sni\u017euje, co\u017e je jeden z navrhovan\u00fdch mechanistick\u00fdch spoj\u016f mezi poklesem NAD+ a fenotypy st\u00e1rnut\u00ed (Rajman, Chwalek &amp; Sinclair, Cell Metab 2018).<\/li>\n<li><strong>PARP-zprost\u0159edkovan\u00e1 oprava DNA<\/strong> \u2014 rodina enzym\u016f poly(ADP-rib\u00f3za) polymer\u00e1zy (PARP) vyu\u017e\u00edv\u00e1 NAD+ jako substr\u00e1t pro reakci na po\u0161kozen\u00ed DNA. Pokles hladin NAD+ znamen\u00e1 m\u00e9n\u011b dostupn\u00e9ho substr\u00e1tu pro opravu DNA, co\u017e vytv\u00e1\u0159\u00ed zp\u011btnou vazbu, kde po\u0161kozen\u00ed DNA d\u00e1le vy\u010derp\u00e1v\u00e1 NAD+.<\/li>\n<\/ul>\n<p>Proto\u017ee tyto t\u0159i dr\u00e1hy spole\u010dn\u011b ovliv\u0148uj\u00ed energetick\u00fd metabolismus, regulaci gen\u016f a \u00fadr\u017ebu genomu, obnova NAD+ je zkoum\u00e1na v neobvykle \u0161irok\u00e9m spektru v\u00fdzkumn\u00fdch kontext\u016f bun\u011b\u010dn\u00e9ho st\u00e1rnut\u00ed \u2014 od metabolick\u00e9ho syndromu po neurodegeneraci a\u017e po svalovou funkci.<\/p>\n<h2>Publikovan\u00e9 v\u00fdzkumn\u00e9 aplikace<\/h2>\n<p>NAD+ se pou\u017e\u00edv\u00e1 v laboratorn\u00edch v\u00fdzkumn\u00fdch kontextech, kter\u00e9 zkoumaj\u00ed:<\/p>\n<ul>\n<li><strong>V\u00fdzkum dlouhov\u011bkosti<\/strong> \u2014 aktivaci sirtuinov\u00e9 dr\u00e1hy a biomarkery bun\u011b\u010dn\u00e9ho st\u00e1rnut\u00ed ve studi\u00edch st\u00e1rnut\u00ed u hlodavc\u016f (Yoshino et al., Cell Metab 2018)<\/li>\n<li><strong>Bun\u011b\u010dn\u00e1 energie \/ funkce mitochondri\u00ed<\/strong> \u2014 produkci ATP a biogenezi mitochondri\u00ed ve v\u00fdzkumu bun\u011b\u010dn\u00e9ho stresu<\/li>\n<li><strong>V\u00fdzkum neuroprotekce<\/strong> \u2014 modely kognitivn\u00edho \u00fabytku a neurologick\u00e9ho st\u00e1rnut\u00ed ve studi\u00edch na hlodavc\u00edch<\/li>\n<li><strong>Metabolick\u00e9 zdrav\u00ed<\/strong> \u2014 citlivost na inzul\u00edn, gluk\u00f3zov\u00e1 homeost\u00e1za a v\u00fdzkum metabolick\u00e9ho syndromu<\/li>\n<li><strong>V\u00fdzkum opravy DNA<\/strong> \u2014 aktivita PARP-dr\u00e1hy a \u00fadr\u017eba genomu v modelech po\u0161kozen\u00ed DNA<\/li>\n<li><strong>V\u00fdzkum proti st\u00e1rnut\u00ed<\/strong> \u2014 slo\u017een\u00e9 markery bun\u011b\u010dn\u00e9ho st\u00e1rnut\u00ed nap\u0159\u00ed\u010d v\u00edce tk\u00e1\u0148ov\u00fdmi syst\u00e9my<\/li>\n<li><strong>Srovn\u00e1vac\u00ed v\u00fdzkum prekurzor\u016f<\/strong> \u2014 vedle prekurzor\u016f NR (nikotinamid ribosid) a NMN (nikotinamid mononukleotid) k izolaci p\u0159\u00edm\u00e9ho NAD+ efektu<\/li>\n<\/ul>\n<p>Pro \u0161ir\u0161\u00ed kontext o dlouhov\u011bkosti a peptidech bun\u011b\u010dn\u00e9ho st\u00e1rnut\u00ed viz <a href=\"https:\/\/medsbase.com\/cs\/peptide-stacks-for-fat-loss\/\">peptidov\u00e9 stacky pro metabolick\u00fd v\u00fdzkum<\/a> a kompletn\u00ed <a href=\"https:\/\/medsbase.com\/cs\/peptides\/\">katalog v\u00fdzkumn\u00fdch peptid\u016f<\/a>.<\/p>\n<h2>Dostupn\u00e9 s\u00edly a koncentrace<\/h2>\n<p>MedsBase skladuje NAD+ v n\u00e1sleduj\u00edc\u00edch lyofilizovan\u00fdch velikostech vialek. Ka\u017ed\u00e1 varianta je dod\u00e1v\u00e1na v balen\u00ed po 10, 20 nebo 30 vialk\u00e1ch:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">S\u00edla vialky<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typick\u00e9 pou\u017eit\u00ed<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Velikosti balen\u00ed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>100 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pilotn\u00ed d\u00e1vkov\u00e1n\u00ed nebo kr\u00e1tkodob\u00e9 protokoly<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 nebo 30 vialek<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>500 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standardn\u00ed v\u00fdzkumn\u00e1 d\u00e1vka, vhodn\u00e1 pro v\u00edcedenn\u00ed protokoly<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 nebo 30 vialek<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1000 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Roz\u0161\u00ed\u0159en\u00fd v\u00fdzkum, IV protokoly, hromadn\u00e1 p\u0159\u00edprava<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 nebo 30 vialek<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>NAD+ vy\u017eaduje vy\u0161\u0161\u00ed absolutn\u00ed d\u00e1vky ne\u017e v\u011bt\u0161ina peptid\u016f (gramy m\u00edsto mikrogram\u016f), proto\u017ee se jedn\u00e1 o koenzym p\u016fsob\u00edc\u00ed na \u00farovni bun\u011b\u010dn\u00fdch z\u00e1sob, nikoliv o sign\u00e1ln\u00ed molekulu p\u016fsob\u00edc\u00ed na \u00farovni receptorov\u00fdch koncentrac\u00ed. Dod\u00e1v\u00e1 se jako lyofilizovan\u00fd pr\u00e1\u0161ek s HPLC \u010distotou 99 %+.<\/p>\n<h2>Srovn\u00e1n\u00ed \u2014 NAD+ vs NR vs NMN<\/h2>\n<p>T\u0159i molekuly dominuj\u00ed v\u00fdzkumn\u00e9mu prostoru NAD+. Ka\u017ed\u00e1 vstupuje do stejn\u00e9 salvage dr\u00e1hy, ale v r\u016fzn\u00fdch vstupn\u00edch bodech:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Krit\u00e9rium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD+<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NR (Nikotinamid Ribosid)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NMN (Nikotinamid Mononukleotid)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Role<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Kone\u010dn\u00fd produkt koenzymu (p\u0159\u00edm\u00fd)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Prekurzor (peror\u00e1ln\u00ed)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Prekurzor (peror\u00e1ln\u00ed nebo SC)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Zp\u016fsob pod\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">SC, IM, IV ve v\u00fdzkumu<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">P\u0159ev\u00e1\u017en\u011b peror\u00e1ln\u00ed<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Peror\u00e1ln\u00ed, SC<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\u20131000 mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013500 mg peror\u00e1ln\u011b<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u20131000 mg peror\u00e1ln\u011b\/SC<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Regula\u010dn\u00ed status<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dietn\u00ed dopln\u011bk FDA GRAS<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Prom\u011bnliv\u00e9 (ned\u00e1vn\u00e9 opat\u0159en\u00ed FDA)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>V\u00fdzkumn\u00edci obvykle vol\u00ed p\u0159\u00edm\u00e9 NAD+ p\u0159ed prekurzory, kdy\u017e cht\u011bj\u00ed obej\u00edt prom\u011bnliv\u00e9 m\u00edry enzymatick\u00e9 konverze (n\u011bkter\u00e9 prekurzory se v ur\u010dit\u00fdch tk\u00e1n\u00edch p\u0159em\u011b\u0148uj\u00ed neefektivn\u011b) nebo kdy\u017e pot\u0159ebuj\u00ed rychl\u00e9 zv\u00fd\u0161en\u00ed plazmatick\u00e9 hladiny. Prekurzory jsou preferov\u00e1ny ve v\u00fdzkumu s trval\u00fdm d\u00e1vkov\u00e1n\u00edm peror\u00e1ln\u00ed aplikac\u00ed.<\/p>\n<h2>Skladov\u00e1n\u00ed a rekonstituce<\/h2>\n<p><strong>P\u0159ed rekonstituci:<\/strong> lyofilizovan\u00e9 lahvi\u010dky skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C v p\u016fvodn\u00edm obalu, stabiln\u00ed a\u017e 36 m\u011bs\u00edc\u016f. NAD+ je citliv\u00fd na sv\u011btlo \u2013 zachovejte p\u016fvodn\u00ed f\u00f3liov\u00fd obal neporu\u0161en\u00fd.<\/p>\n<p><strong>Postup rekonstituce:<\/strong> injektujte bakteriostatickou vodu po bo\u010dn\u00ed st\u011bn\u011b lahvi\u010dky podle v\u00fd\u0161e uveden\u00e9ho sch\u00e9matu. Lahvi\u010dky NAD+ pou\u017e\u00edvaj\u00ed v\u011bt\u0161\u00ed objemy rekonstituce ne\u017e lahvi\u010dky s peptidy kv\u016fli v\u011bt\u0161\u00ed absolutn\u00ed d\u00e1vce. Jemn\u011b zakru\u017ete \u2013 ne <strong>ne<\/strong> prot\u0159epejte \u2014 a nechte 5\u201310 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed.<\/p>\n<p><strong>Po rekonstituci:<\/strong> skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C, chr\u00e1n\u011bn\u00e9 p\u0159ed sv\u011btlem, a pou\u017eijte do 30 dn\u016f. Rekonstituovan\u00fd NAD+ se m\u016f\u017ee rozkl\u00e1dat rychleji ne\u017e peptidy \u2014 \u017elut\u00e9 a\u017e hn\u011bd\u00e9 zabarven\u00ed signalizuje oxidaci a m\u011blo by v\u00e9st k vyhozen\u00ed.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>K \u010demu se NAD+ pou\u017e\u00edv\u00e1 ve v\u00fdzkumu?<\/h3>\n<p>NAD+ se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu zam\u011b\u0159en\u00e9m na bun\u011b\u010dn\u00e9 st\u00e1rnut\u00ed, aktivaci sirtuinov\u00e9 dr\u00e1hy, funkci mitochondri\u00ed, opravu DNA prost\u0159ednictv\u00edm PARP, neuroprotekci a modely metabolick\u00e9ho zdrav\u00ed. Je <strong>ne<\/strong> schv\u00e1len FDA pro terapeutick\u00e9 pou\u017eit\u00ed a je zde prod\u00e1v\u00e1n v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<h3>Je NAD+ peptid?<\/h3>\n<p>Ne. NAD+ je dinukleotidov\u00fd koenzym, nikoli peptid. \u010casto je dod\u00e1v\u00e1n prost\u0159ednictv\u00edm dodavatel\u016f pro v\u00fdzkum peptid\u016f, proto\u017ee v\u00fdzkumn\u00edci dlouhov\u011bkosti jej \u010dasto pou\u017e\u00edvaj\u00ed spolu s v\u00fdzkumn\u00fdmi protokoly peptid\u016f a ob\u011b kategorie sd\u00edlej\u00ed form\u00e1t rekonstituce lyofilizovan\u00e9ho pr\u00e1\u0161ku s BAC vodou.<\/p>\n<h3>Jak\u00e1 je typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka NAD+?<\/h3>\n<p>Publikovan\u00e9 preklinick\u00e9 protokoly se v\u00fdrazn\u011b li\u0161\u00ed v z\u00e1vislosti na kontextu v\u00fdzkumu. B\u011b\u017en\u00e9 rozsahy: 50\u2013100 mg SC\/IM denn\u011b pro v\u00fdzkum dlouhov\u011bkosti, 250\u2013500 mg pro v\u00fdzkum bun\u011b\u010dn\u00e9 energie a a\u017e 1 000 mg ve v\u00fdzkumn\u00fdch protokolech IV. 500 mg lahvi\u010dka rekonstituovan\u00e1 s 5,0 mL bakteriostatick\u00e9 vody poskytne 100 mg\/mL \u2014 50 d\u00edlek na U-100 st\u0159\u00edka\u010dce dod\u00e1 50 mg.<\/p>\n<h3>Je NAD+ schv\u00e1len FDA?<\/h3>\n<p>Ne. NAD+ nen\u00ed terapeutikum schv\u00e1len\u00e9 FDA. Byl studov\u00e1n v klinick\u00fdch kontextech (v\u010detn\u011b wellness klinik s \u201cterapi\u00ed NAD+\u201d), ale nedostal schv\u00e1len\u00ed FDA pro \u017e\u00e1dnou konkr\u00e9tn\u00ed indikaci. Ve\u0161ker\u00fd NAD+ prod\u00e1van\u00fd dodavateli pouze pro v\u00fdzkum je ur\u010den pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<h3>Jak se NAD+ li\u0161\u00ed od NR nebo NMN?<\/h3>\n<p>NR (nikotinamid ribosid) a NMN (nikotinamid mononukleotid) jsou <em>prekurzory<\/em> kter\u00e9 bu\u0148ky p\u0159em\u011b\u0148uj\u00ed na NAD+ prost\u0159ednictv\u00edm salvage dr\u00e1hy. P\u0159\u00edm\u00fd NAD+ tuto konverzn\u00ed f\u00e1zi obch\u00e1z\u00ed. V\u00fdzkumn\u00edci vol\u00ed p\u0159\u00edm\u00fd NAD+, kdy\u017e cht\u011bj\u00ed p\u0159esn\u011b kontrolovat hladiny v plazm\u011b; prekurzory se pou\u017e\u00edvaj\u00ed pro v\u00fdzkum trval\u00e9ho peror\u00e1ln\u00edho d\u00e1vkov\u00e1n\u00ed, kde je enzymatick\u00e1 konverze p\u0159ijateln\u00e1.<\/p>\n<h3>Jak by m\u011bl b\u00fdt NAD+ skladov\u00e1n?<\/h3>\n<p>Lyofilizovan\u00e9 lahvi\u010dky: skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C v p\u016fvodn\u00edm obalu, chr\u00e1n\u011bn\u00e9 p\u0159ed sv\u011btlem. Stabiln\u00ed a\u017e 36 m\u011bs\u00edc\u016f. Rekonstituovan\u00fd roztok: skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C, chr\u00e1n\u011bn\u00fd p\u0159ed sv\u011btlem, pou\u017eijte do 30 dn\u016f. NAD+ je citliv\u011bj\u0161\u00ed na sv\u011btlo a oxidaci ne\u017e v\u011bt\u0161ina peptid\u016f.<\/p>\n<h3>Jak m\u00e1m rekonstituovat NAD+?<\/h3>\n<p>Postupujte podle v\u00fd\u0161e uveden\u00e9ho rekonstitu\u010dn\u00edho sch\u00e9matu. P\u0159idejte bakteriostatickou vodu po stran\u011b lahvi\u010dky, jemn\u011b zakru\u017ete a nechte 5\u201310 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. NAD+ vy\u017eaduje v\u011bt\u0161\u00ed objemy rekonstitu\u010dn\u00edho roztoku ne\u017e peptidy kv\u016fli v\u011bt\u0161\u00ed absolutn\u00ed d\u00e1vce. Ne <strong>ne<\/strong> t\u0159epat.<\/p>\n<h3>M\u016f\u017ee b\u00fdt NAD+ kombinov\u00e1n s peptidy ve v\u00fdzkumu?<\/h3>\n<p>Ano. NAD+ je \u010dasto studov\u00e1n spole\u010dn\u011b s <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu<\/a> (v\u00fdzkum bun\u011b\u010dn\u00e9 energie), <a href=\"https:\/\/medsbase.com\/cs\/ipamorelin\/\">ipamorelin<\/a> (v\u00fdzkum metabolick\u00e9 osy) a dal\u0161\u00edmi peptidy dlouhov\u011bkosti. Proto\u017ee NAD+ p\u016fsob\u00ed na \u00farovni koenzym\u016f sp\u00ed\u0161e ne\u017e na receptorech, farmakologick\u00e9 interakce s peptidy jsou minim\u00e1ln\u00ed.<\/p>\n<h3>Jak\u00e9 s\u00edly nab\u00edz\u00ed MedsBase?<\/h3>\n<p>MedsBase nab\u00edz\u00ed NAD+ v lyofilizovan\u00fdch vial\u00e1ch o s\u00edle 100 mg, 500 mg a 1000 mg. Ka\u017ed\u00e1 s\u00edla je dostupn\u00e1 v balen\u00edch po 10, 20 nebo 30 vial\u00e1ch. V\u0161echny vials jsou dod\u00e1v\u00e1ny s \u010distotou 99%+ HPLC a certifik\u00e1tem anal\u00fdzy na vy\u017e\u00e1d\u00e1n\u00ed.<\/p>\n<h3>Zp\u016fsobuje NAD+ vedlej\u0161\u00ed \u00fa\u010dinky ve v\u00fdzkumu?<\/h3>\n<p>Nej\u010dast\u011bji popisovan\u00fdm \u00fa\u010dinkem ve v\u00fdzkumu a klinick\u00e9m pou\u017eit\u00ed je \u201cn\u00e1val\u201d p\u0159i nitro\u017eiln\u00edm pod\u00e1n\u00ed s rychlou infuzn\u00ed rychlost\u00ed \u2013 p\u0159edpokl\u00e1d\u00e1 se, \u017ee jde o p\u0159echodn\u00fd vaskul\u00e1rn\u00ed efekt. Ostatn\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky se p\u0159i typick\u00fdch v\u00fdzkumn\u00fdch d\u00e1vk\u00e1ch zdaj\u00ed minim\u00e1ln\u00ed. Proto\u017ee NAD+ je endogenn\u00ed koenzym, farmakologick\u00e9 obavy jsou obecn\u011b ni\u017e\u0161\u00ed ne\u017e u exogenn\u00edch xenobiotick\u00fdch slou\u010denin.<\/p>\n<h3>Jak\u00fd je biologick\u00fd polo\u010das NAD+?<\/h3>\n<p>Endogenn\u00ed NAD+ m\u00e1 biologick\u00fd polo\u010das p\u0159ibli\u017en\u011b 1\u20132 hodiny ve v\u011bt\u0161in\u011b typ\u016f bun\u011bk, s v\u00fdrazn\u00fdmi rozd\u00edly podle tk\u00e1n\u011b. Ve v\u00fdzkumu p\u0159edklinick\u00e9ho nitro\u017eiln\u00edho pod\u00e1n\u00ed je exogenn\u00ed NAD+ rychle p\u0159ij\u00edm\u00e1n tk\u00e1n\u011bmi a p\u0159em\u011bn\u011bn na n\u00e1sledn\u00e9 metabolity (NADH, NAAD, ADPR). Lyofilizovan\u00e1 forma pro laboratorn\u00ed rekonstituci se typicky pou\u017e\u00edv\u00e1 v modelech akutn\u00ed suplementace nebo bun\u011b\u010dn\u00e9ho v\u00fdzkumu.<\/p>\n<h3>Jak se p\u0159\u00edm\u00e1 suplementace NAD+ porovn\u00e1v\u00e1 s NMN a NR ve v\u00fdzkumu?<\/h3>\n<p>NMN (nikotinamidmononukleotid) a NR (nikotinamidribosid) jsou prekurzory NAD+, kter\u00e9 se intracelul\u00e1rn\u011b p\u0159em\u011b\u0148uj\u00ed na NAD+. P\u0159\u00edm\u00e1 suplementace NAD+ je studov\u00e1na pro v\u00fdzkumn\u00e9 modely, kde m\u016f\u017ee b\u00fdt p\u0159em\u011bna prekurzor\u016f limitov\u00e1na rychlost\u00ed. V\u0161echny t\u0159i p\u0159\u00edstupy jsou aktivn\u00edmi oblastmi v\u00fdzkumu dlouhov\u011bkosti a bioenergetiky, s r\u016fzn\u00fdmi profily biologick\u00e9 dostupnosti a metabolick\u00e9 p\u0159em\u011bny.<\/p>\n<h3>Mohu si objednat NAD+ pro mezin\u00e1rodn\u00ed p\u0159epravu?<\/h3>\n<p>Ano. MedsBase expeduje NAD+ do cel\u00e9ho sv\u011bta prost\u0159ednictv\u00edm na\u0161\u00ed specializovan\u00e9 s\u00edt\u011b pro p\u0159epravu peptid\u016f. Objedn\u00e1vky NAD+ kvalifikuj\u00ed pro na\u0161i samostatnou slu\u017ebu p\u0159epravy peptid\u016f. Z\u00e1silky jsou odes\u00edl\u00e1ny v teplotn\u011b kontrolovan\u00e9m, sv\u011btlochrann\u00e9m balen\u00ed s pln\u00fdm sledov\u00e1n\u00edm.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Dal\u0161\u00ed peptidy pro v\u00fdzkum regenerace a v\u00fdkonnosti<\/h2>\n<ul>\n<li><a href=\"\/cs\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 v\u00fdzkum regenerace \u0161lach, vaz\u016f a st\u0159ev<\/li>\n<li><a href=\"\/cs\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Fragment Thymosin Beta-4 \u2014 v\u00fdzkum regenerace m\u011bkk\u00fdch tk\u00e1n\u00ed a c\u00e9v<\/li>\n<li><a href=\"\/cs\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Selektivn\u00ed agonista ghrelinu \u2014 \u010dist\u00fd pulz r\u016fstov\u00e9ho hormonu bez kortizolu\/prolaktinu<\/li>\n<li><a href=\"\/cs\/cjc-1295-with-dac\/\"><strong>CJC-1295 with DAC<\/strong><\/a> \u2014 Analog GHRH s prodlou\u017een\u00fdm polo\u010dasem<\/li>\n<li><a href=\"\/cs\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 M\u011b\u010fn\u00fd peptid \u2014 v\u00fdzkum regenerace k\u016f\u017ee a pojivov\u00e9 tk\u00e1n\u011b<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Dal\u0161\u00ed \u010dten\u00ed<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 P\u0159e\u010dt\u011bte si v\u00fdzkum tohoto koenzymu<\/strong><\/p>\n<p style=\"margin: 0;\">P\u0159e\u010dt\u011bte si n\u00e1\u0161 kompletn\u00ed pr\u016fvodce zalo\u017een\u00fd na d\u016fkazech: <a href=\"https:\/\/medsbase.com\/cs\/nad-plus-coenzyme-longevity-guide\/\"><strong>NAD+ \u2014 mechanismus, v\u00fdzkum dlouhov\u011bkosti a v\u011bdeck\u00e1 fakta<\/strong><\/a>. Pokr\u00fdv\u00e1 biologii sirtuin\u016f a PARP, hypot\u00e9zu poklesu NAD+, srovn\u00e1n\u00ed prekurzor\u016f (NR \/ NMN), publikovan\u00e9 v\u00fdzkumn\u00e9 d\u00e1vkov\u00e9 rozsahy, protokoly pro rekonstituci a bezpe\u010dnostn\u00ed pozn\u00e1mky.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Zvy\u0161uje bun\u011b\u010dnou energii<br \/>\n\u2705 Podporuje funkci mitochondri\u00ed<br \/>\n\u2705 Podporuje metabolickou rovnov\u00e1hu<br \/>\n\u2705 Posiluje bun\u011b\u010dnou opravu<br \/>\n\u2705 Zlep\u0161uje dr\u00e1hy vitality<\/p>\n<p><strong>NAD\u207a<\/strong> obsahuje syntetickou peptidovou slou\u010deninu.<\/p>","protected":false},"featured_media":70968,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5452,5453],"class_list":{"0":"post-68840","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-nad","8":"product_tag-nicotinamide-adenine-dinucleotide","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/68840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=68840"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/70968"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=68840"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=68840"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=68840"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=68840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}